LRLisa Richter

Lisa Richter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lisa Richter has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A randomized controlled trial, process and economic evaluation, comparing multimodal care intervention to standard care for older adults in Mecklenburg-Western Pomerania, Germany: study protocol of the intensified interprofessional outpatient therapy for geriatric patients (InATheGer) model

    by Lorena Dini, Ana Ordonez-Cruickshank, Martha Koppelow, Anja Wollny, Lisa Richter, Anne Daubmann, Anna Suling, Nicolas Pardey, Pia M. Stapelfeldt, Sabine Meinhold, et al.

    Background: Geriatric patients with multimorbidity and functional impairments represent a rapidly growing population that requires coordinated outpatient care to maintain independence and quality of life. In Germany, particularly in rural regions, outpatient care is primarily delivered by family doctors and general practitioners within a fragmented system that often lacks sufficient interdisciplinary collaboration. This fragmentation limits access to comprehensive, continuous care. Multimodal, interprofessional interventions that integrate medical, therapeutic, and psychosocial support may improve functional outcomes and reduce hospitalizations in these populations. This study aims to evaluate the effectiveness and efficiency of a structured, multimodal, and interprofessional coordinated outpatient care model for geriatric patients. Methods: This multicenter randomized controlled trial will enroll 540 geriatric patients aged 70 years and older across three regional outpatient centers (intervention centers) in Mecklenburg–Western Pomerania (MV), Germany. Participants will be randomized 1:1 to receive either standard care or the Intensified Interprofessional Outpatient Therapy for Geriatric Patients (InATheGer) intervention. The intervention group will participate in a 14-week interprofessional outpatient program, comprising 20 therapy days with multimodal therapy sessions coordinated by a trained care manager (“InA-Manager”). Assessments will be conducted at baseline (before randomization), 18 weeks, and 31 weeks post-baseline. The primary outcome measure is the improvement in mobility and functional independence 18 weeks post-baseline, measured by an adapted Functional Independence Measure (FIM). Secondary outcomes include change in quality of life (EQ-5D-5 L), medication use, healthcare utilization, and costs. A qualitative process evaluation will complement the trial to explore implementation and contextual factors. Discussion: If the InATheGer model demonstrates clinical effectiveness and cost-effectiveness, it will provide policymakers and healthcare stakeholders with evidence to inform the development and scaling of coordinated, interprofessional outpatient care for geriatric patients. Broad implementation of this model within routine geriatric outpatient care could enhance functional independence and quality of life among ageing populations while improving healthcare system efficiency. Trial registration: German Clinical Trials Register (DRKS) registration number DRKS00036229. Prospectively registered on 08 April 2025.

  • Open Access

    The Impact of Psychosocial Aspects as Risk Factors for Long-Term Illnesses in General Practice: Protocol for a Scoping Review

    by Kathrin Epple, Julia Nothacker, Lisa Richter, Christin Löffler, Ralf Jendyk, Andreas Dierich

    Background: Psychosocial risk factors increase the risk of long-term illnesses and prolonged return-to-work processes, with serious consequences for individuals as well as society. In general practice, psychosocial risk factors are captured comprehensively because general practitioners usually care for patients for years and know the patients’ entire social environment. Numerous studies have been conducted on aspects of psychosocial risk factors. However, a comprehensive, unrestricted summary of psychosocial risk factors is currently lacking. Objective: The present review aims to address this gap by providing an overview of psychosocial risk factors with relevance for Western and Western-oriented countries. Methods: This scoping review will be conducted in accordance with the methodology outlined in the Joanna Briggs Institute Manual for Evidence Synthesis in a 3-stage search strategy. Searched databases were MEDLINE, the Cochrane Library, Embase, and Web of Science. Each reference will be screened by 2 reviewers independently. The findings will be reported according to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. Results: A literature search conducted on September 8, 2025, resulted in 8515 articles after deduplication. Title and abstract screening started on September 10, 2025. It is estimated that screening will be completed in April 2026, followed by 2 to 3 months to complete data extraction and 1 to 2 months to draft the manuscript. The goal is to submit the scoping review manuscript in September 2026. We expect to identify various psychosocial aspects affecting long-term illnesses and return-to-work processes. Conclusions: Psychosocial risk factors play an important role in the development of long-term illnesses and prolonged return-to-work processes as they are often not communicated by patients but may influence the severity, duration, and progression of long-term illnesses. Evidence-based knowledge about comprehensive psychosocial risk factors will increase awareness of psychosocial aspects among physicians treating patients with long-term illnesses. This will help identify multidisciplinary prevention strategies for patients with long-term illnesses and relieve return-to-work processes.

  • Open Access

    The impact of psychosocial aspects as risk factors for long-term illnesses in general practice: A scoping review protocol (Preprint)

    by Kathrin Epple, Julia Nothacker, Lisa Richter, Christin Löffler, Ralf Jendyk, Andreas Dierich

    BACKGROUND Psychosocial risk factors increase the risk for long-term illnesses and for prolonged return-to-work processes with serious consequences for individuals as well as society. In general practice, psychosocial risk factors are captured comprehensively, because general practitioners usually care for patients for years and know the patient´s entire social environment. Numerous studies have been conducted on aspects of psychosocial risk factors. However, a comprehensive, unrestricted summary of psychosocial risk factors is currently lacking. OBJECTIVE The present review aims to address this gap by providing an overview of psychosocial risk factors with relevance for Western(-oriented) countries. METHODS This scoping review will be conducted in accordance with the methodology outlined in the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis in a three-stage search strategy. Searched databases are Medline, the Cochrane Library, Embase and Web of Science. Each reference will be screened by two reviewers independently. The findings will be reported according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping reviews (PRISMA-ScR). RESULTS Literature search conducted September 8, 2025 resulted in 8,515 articles after deduplication, so title/abstract screening started September 10, 2025. We expect to identify various psychosocial aspects affecting long-term illnesses and return-to-work processes. CONCLUSIONS Psychosocial risk factors play a significant role in the development of long-term illnesses and prolonged return-to-work processes. Evidence-based knowledge about comprehensive psychosocial risk factors will increase awareness of psychosocial aspects among physicians, treating patients with long-term illnesses. This will help to identify multidisciplinary prevention-strategies for patients with long-term illnesses and relieve return-to-work processes. CLINICALTRIAL This scoping review was registered on the Open Science Framework on June 27, 2025: https://doi.org/10.17605/OSF.IO/FSYM6. Clinical trial number: not applicable.